Capsule strength clarity, finished-bottle presentation, documentation, label accuracy, storage expectations, and fulfillment handling all matter
Matrix/collagen support and fibroblast migration in tendon/ligament models
Instead, ALA may work best as a complementary therapy alongside standard treatments and lifestyle changes
Areas of large hemorrhage, pigmentation, fibrosis, or necrosis are present
Novo Nordisk files for FDA approval for CagriSema, the first once-weekly combination of GLP1 and amylin analogues owenhaskins Dec 19, 2025 2 min read Novo Nordisk has submitted a New Drug Application (NDA) to the FDA for once-weekly CagriSema (cagrilintide 2.4 mg and semaglutide 2.4 mg) injection, to be used with a reduced-calorie diet and increased physical activity, to reduce excess body weight and maintain weight reduction long term in adults with obesity or overweight in the presence of at least one weight-related comorbid condition